Jonathan C Javitt's Net Worth
$126 Thousand
Who is Jonathan C Javitt?
Jonathan C Javitt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include QUALITY SYSTEMS INC, BRAINSTORM CELL THERAPEUTICS INC, and NRX Pharmaceuticals, Inc..
SEC CIK
Jonathan C Javitt's CIK is 0001303782
Past Insider Trading and Trends
2005 was Jonathan C Javitt's most active year for acquiring shares with 9 total transactions. Jonathan C Javitt's most active month to acquire stocks was the month of May. 2008 was Jonathan C Javitt's most active year for disposing of shares, totalling 2 transactions. Jonathan C Javitt's most active month to dispose stocks was the month of July. 2022 saw Jonathan C Javitt paying a total of $5,858,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2022 Jonathan C Javitt cashed out on 400,000 shares for a total of $400,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
QUALITY SYSTEMS INC (NXGN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.60% | 4K |
$49.16 | $196,189.81 | 64.59K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BRAINSTORM CELL THERAPEUTICS INC (BCLI) Snapshot price: $0.3717
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
| +100.00% | 960K |
$0.13 |
—
| 1.92M |
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NRX Pharmaceuticals, Inc. (NRXP) Snapshot price: $0.398
Chief Scientist
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.87% | 100K |
$0.33 | $33,000.00 | 446.33K |
Aug 23
| |||
Form 4
| +136.68% | 200K |
$0.32 | $64,400.00 | 346.33K |
Aug 22
| |||
Form 4
| -3.01% | -400.00K |
$1.00 | -$400,000.00 | 12.9M |
Dec 7
| |||
Form 4/A
| +215.83% | 100K |
$0.58 | $58,000.00 | 146.33K |
Jun 1
| |||
Form 4
| +215.83% | 100K |
$58.00 | $5,800,000.00 | 146.33K |
Jun 1
| |||
Form 4
|
∞
| 14.82M |
—
|
—
| 14.82M |
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||